These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28373719)

  • 21. Segments in the Amyloid Core that Distinguish Hamster from Mouse Prion Fibrils.
    Shen HC; Chen YH; Lin YS; Chu BK; Liang CS; Yang CC; Chen RP
    Neurochem Res; 2019 Jun; 44(6):1399-1409. PubMed ID: 30603982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Structure of the Infectious Prion Protein and Its Propagation.
    Requena JR; Wille H
    Prog Mol Biol Transl Sci; 2017; 150():341-359. PubMed ID: 28838667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pressure Reveals Unique Conformational Features in Prion Protein Fibril Diversity.
    Torrent J; Martin D; Noinville S; Yin Y; Doumic M; Moudjou M; Béringue V; Rezaei H
    Sci Rep; 2019 Feb; 9(1):2802. PubMed ID: 30808892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
    Nyström S; Hammarström P
    Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Biology of PrP Prions.
    Stubbs G; Stöhr J
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity.
    Yen CF; Harischandra DS; Kanthasamy A; Sivasankar S
    Sci Adv; 2016 Jul; 2(7):e1600014. PubMed ID: 27419232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dodecylphosphocholine Micelles Induce Amyloid Formation of the PrP(110-136) Peptide via an α-Helical Metastable Conformation.
    Sauvé S; Aubin Y
    PLoS One; 2016; 11(12):e0168021. PubMed ID: 27930722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble polymorphic bank vole prion proteins induced by co-expression of quiescin sulfhydryl oxidase in E. coli and their aggregation behaviors.
    Abskharon R; Dang J; Elfarash A; Wang Z; Shen P; Zou LS; Hassan S; Wang F; Fujioka H; Steyaert J; Mulaj M; Surewicz WK; Castilla J; Wohlkonig A; Zou WQ
    Microb Cell Fact; 2017 Oct; 16(1):170. PubMed ID: 28978309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation.
    Hafner-Bratkovic I; Gaspersic J; Smid LM; Bresjanac M; Jerala R
    J Neurochem; 2008 Mar; 104(6):1553-64. PubMed ID: 17996023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Octapeptide Repeats on Prion Folding and Misfolding.
    Yu KH; Huang MY; Lee YR; Lin YK; Chen HR; Lee CI
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggregation Condition-Structure Relationship of Mouse Prion Protein Fibrils.
    Fridmanis J; Toleikis Z; Sneideris T; Ziaunys M; Bobrovs R; Smirnovas V; Jaudzems K
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of distinct prion protein amyloid fibrils under identical experimental conditions.
    Ziaunys M; Sneideris T; Smirnovas V
    Sci Rep; 2020 Mar; 10(1):4572. PubMed ID: 32165692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seeding and cross-seeding fibrillation of N-terminal prion protein peptides PrP(120-144).
    Wang Y; Hall CK
    Protein Sci; 2018 Jul; 27(7):1304-1313. PubMed ID: 29637634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.